The GRUrocast is an educational resource from Carden Jennings Publishing and Grand Rounds in Urology, designed for urology professionals to listen, learn, and receive practical advice from experts in the field of genitourinary diseases. Listen here or on the streaming platform of your choice.
In this episode, an expert panel reviews a bladder cancer patient journey, including symptom recognition, diagnostic evaluation, treatment decision-making, systemic therapy, and survivorship considerations.
Sim P. Porten, MD, MPH, FACS, Associate Professor of Urology, University of California, San Francisco, San Francisco, California, presents a complex bladder preservation case to a group of experts, and highlights the rising circulating tumor DNA in the absence of radiographic or pathologic recurrence, prompting debate regarding surveillance versus systemic therapy.
Evan Y. Yu, MD, Professor of Oncology, University of Washington, Seattle, Washington, reviews novel targeted treatment strategies for prostate cancer beyond androgen receptor and PSMA-directed therapies.
Dr. Rahul Mehan discusses integrating diagnosis, treatment, and multidisciplinary care into a urology-led one-stop clinic for prostate cancer management.
Steven E. Finkelstein, MD, DABR, FACRO, and Patrick Soon-Shiong, MD, delve into the interplay between radiation therapy and immunotherapy in prostate cancer care.
Leonard G. Gomella, MD, FACS, and Brian T. Helfand, MD, PhD, discuss genetic testing in prostate cancer risk assessment and management.
A panel discusses intermittent versus continuous androgen deprivation therapy (ADT) and its impact on prostate cancer outcomes.
A panel of experts discuss advancements in managing benign prostatic hyperplasia, focusing on minimally invasive surgical therapies.
A panel of experts explores the complexities of salvage treatment following focal therapy in prostate cancer.
Daniel P. Petrylak, MD, leads a discussion exploring the evolving landscape of bladder cancer treatment.
Brian J. Flynn, MD, and Alan J. Wein, MD, PhD (Hon), FACS, discuss the evolution of functional and reconstructive urology.
Arvin K. George, MD, Veeru Kasivisvanathan, MBBS, BSc, FRCS, PhD, MSc, PGCrert, and Sadhna Verma, MD, MBA, FSAR, explore prostate cancer imaging, biopsy strategies, and treatment.
Bernard H. Bochner, MD, FACS, is a Urologic Surgeon, from the Memorial Sloan Kettering Cancer Center. He leads a panel of experts in discussing UTUC treatment and individualized patient care.